306 related articles for article (PubMed ID: 30281547)
1. Antibiotic Resistance Among Pediatric-Sourced Ocular Pathogens: 8-Year Findings From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.
Alter SJ; Sanfilippo CM; Asbell PA; DeCory HH
Pediatr Infect Dis J; 2019 Feb; 38(2):138-145. PubMed ID: 30281547
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Resistance Among Ocular Pathogens in the United States: Five-Year Results From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.
Asbell PA; Sanfilippo CM; Pillar CM; DeCory HH; Sahm DF; Morris TW
JAMA Ophthalmol; 2015 Dec; 133(12):1445-54. PubMed ID: 26502312
[TBL] [Abstract][Full Text] [Related]
3. Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 2018.
Asbell PA; Sanfilippo CM; Sahm DF; DeCory HH
JAMA Ophthalmol; 2020 May; 138(5):439-450. PubMed ID: 32271355
[TBL] [Abstract][Full Text] [Related]
4. Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 surveillance study.
Haas W; Pillar CM; Torres M; Morris TW; Sahm DF
Am J Ophthalmol; 2011 Oct; 152(4):567-574.e3. PubMed ID: 21652021
[TBL] [Abstract][Full Text] [Related]
5. Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) surveillance study.
Asbell PA; DeCory HH
PLoS One; 2018; 13(10):e0205814. PubMed ID: 30335799
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance among ocular pathogens: current trends from the ARMOR surveillance study (2009-2016).
Thomas RK; Melton R; Asbell PA
Clin Optom (Auckl); 2019; 11():15-26. PubMed ID: 30881168
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance of bacterial pathogens isolated from the conjunctiva in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) surveillance study (2009-2021).
Asbell PA; Sanfilippo CM; DeCory HH
Diagn Microbiol Infect Dis; 2024 Jan; 108(1):116069. PubMed ID: 37918187
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic susceptibility of bacterial pathogens isolated from the aqueous and vitreous humour in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) Surveillance Study: 2009-2020 update.
Asbell PA; Sanfilippo CM; Mah FS
J Glob Antimicrob Resist; 2022 Jun; 29():236-240. PubMed ID: 35339737
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Antibiotic Resistance among Bacteria from the Cornea in the Antibiotic Resistance Monitoring in Ocular MicRoorganisms Surveillance Study.
Thomas RK; Melton R; Vollmer PM; Asbell PA
Optom Vis Sci; 2021 Sep; 98(9):1113-1121. PubMed ID: 34510155
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Resistance Rates by Geographic Region Among Ocular Pathogens Collected During the ARMOR Surveillance Study.
Asbell PA; Pandit RT; Sanfilippo CM
Ophthalmol Ther; 2018 Dec; 7(2):417-429. PubMed ID: 30094698
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
Morfin-Otero R; Noriega ER; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
Zhang Z; Chen M; Yu Y; Pan S; Liu Y
Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308
[TBL] [Abstract][Full Text] [Related]
13. Ocular Pathogens and Antibiotic Sensitivity in Bacterial Keratitis Isolates at King Khaled Eye Specialist Hospital, 2011 to 2014.
Al-Dhaheri HS; Al-Tamimi MD; Khandekar RB; Khan M; Stone DU
Cornea; 2016 Jun; 35(6):789-94. PubMed ID: 27078003
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of the Activity of Aminoglycosides and Fluoroquinolones Against Ophthalmic Pathogens from Europe in 2010-2011.
Sanfilippo CM; Morrissey I; Janes R; Morris TW
Curr Eye Res; 2016 May; 41(5):581-9. PubMed ID: 26200173
[TBL] [Abstract][Full Text] [Related]
15. Bacterial pathogens associated with external ocular infections alongside eminent proportion of multidrug resistant isolates at the University of Gondar Hospital, northwest Ethiopia.
Getahun E; Gelaw B; Assefa A; Assefa Y; Amsalu A
BMC Ophthalmol; 2017 Aug; 17(1):151. PubMed ID: 28830451
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
17. Shifting trends in bacterial keratitis in Toronto: an 11-year review.
Lichtinger A; Yeung SN; Kim P; Amiran MD; Iovieno A; Elbaz U; Ku JY; Wolff R; Rootman DS; Slomovic AR
Ophthalmology; 2012 Sep; 119(9):1785-90. PubMed ID: 22627118
[TBL] [Abstract][Full Text] [Related]
18. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
Peric M; Browne FA; Jacobs MR; Appelbaum PC
Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of omadacycline activity tested against clinical isolates from the United States and Europe: Results from the SENTRY Antimicrobial Surveillance Programme, 2017.
Huband MD; Pfaller MA; Shortridge D; Flamm RK
J Glob Antimicrob Resist; 2019 Dec; 19():56-63. PubMed ID: 30825698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
